Katrin Schlack

PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis

Robert Seifert, Katharina Kessel, Katrin Schlack et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 140 citations · Full text

<i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz et al. · Journal of Clinical Oncology · 2024 · 95 citations · Full text

Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving ¹⁷⁷Lu-PSMA-617

Katharina Kessel, Robert Seifert, Michael Schäfers et al. · Theranostics · 2019 · 79 citations · Full text

Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock

Sebastian Rehberg, Christian Ertmer, Gabriele Köhler et al. · Intensive Care Medicine · 2009 · 49 citations

Animal Physiology, Arginine Vasopressin, Veterinary Science +4

Radioligand therapy using [177Lu]Lu-PSMA-617 in mCRPC: a pre-VISION single-center analysis

Robert Seifert, Katharina Kessel, Katrin Schlack et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 45 citations · Full text